Page last updated: 2024-08-24

triazoles and exendin (9-39)

triazoles has been researched along with exendin (9-39) in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ardestani, A; Dharmadhikari, G; Kerr-Conte, J; Klein, T; Laue, S; Maedler, K; Pattou, F; Schumann, DM; Shah, P	1
Hiratsuka, A; Iwanaga, T; Lee, EY; Miki, T; Morita, A; Mukai, E; Takatani, T	1

Other Studies

2 other study(ies) available for triazoles and exendin (9-39)

Article	Year
The DPP-4 inhibitor linagliptin restores β-cell function and survival in human isolated islets through GLP-1 stabilization. The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:7 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cell Survival; Cytokines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Drug Inverse Agonism; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Linagliptin; Palmitic Acid; Peptide Fragments; Protein Stability; Purines; Pyrazines; Quinazolines; Recombinant Proteins; Sitagliptin Phosphate; Tissue Culture Techniques; Triazoles	2013
Distinct effects of dipeptidyl peptidase-4 inhibitor and glucagon-like peptide-1 receptor agonist on islet morphology and function. Endocrine, 2016, Volume: 51, Issue:3 Topics: Animals; Cell Death; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide-1 Receptor; Glucose; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Liraglutide; Mice; Pancreatic Function Tests; Peptide Fragments; Regeneration; Signal Transduction; Triazoles	2016

Article

Year

The DPP-4 inhibitor linagliptin restores β-cell function and survival in human isolated islets through GLP-1 stabilization.

The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:7

Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cell Survival; Cytokines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Drug Inverse Agonism; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Linagliptin; Palmitic Acid; Peptide Fragments; Protein Stability; Purines; Pyrazines; Quinazolines; Recombinant Proteins; Sitagliptin Phosphate; Tissue Culture Techniques; Triazoles

2013

Distinct effects of dipeptidyl peptidase-4 inhibitor and glucagon-like peptide-1 receptor agonist on islet morphology and function.

Endocrine, 2016, Volume: 51, Issue:3

Topics: Animals; Cell Death; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide-1 Receptor; Glucose; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Liraglutide; Mice; Pancreatic Function Tests; Peptide Fragments; Regeneration; Signal Transduction; Triazoles

2016